Literature DB >> 21763725

Tripeptide inhibitors of dengue and West Nile virus NS2B-NS3 protease.

Andreas Schüller1, Zheng Yin, C S Brian Chia, Danny N P Doan, Hyeong-Kyu Kim, Luqing Shang, Teck Peng Loh, Jeffery Hill, Subhash G Vasudevan.   

Abstract

A series of tripeptide aldehyde inhibitors were synthesized and their inhibitory effect against dengue virus type 2 (DENV2) and West Nile virus (WNV) NS3 protease was evaluated side by side with the aim to discover potent flaviviral protease inhibitors and to examine differences in specificity of the two proteases. The synthesized inhibitors feature a varied N-terminal cap group and side chain modifications of a P2-lysine residue. In general a much stronger inhibitory effect of the tripeptide inhibitors was observed toward WNV protease. The inhibitory concentrations against DENV2 protease were in the micromolar range while they were submicromolar against WNV. The data suggest that a P2-arginine shifts the specificity toward DENV2 protease while WNV protease favors a lysine in the P2 position. Peptides with an extended P2-lysine failed to inhibit DENV2 protease suggesting a size-constrained S2 pocket. Our results generally encourage the investigation of di- and tripeptide aldehydes as inhibitors of DENV and WNV protease.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21763725     DOI: 10.1016/j.antiviral.2011.07.002

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  18 in total

1.  C-terminal residue optimization and fragment merging: discovery of a potent Peptide-hybrid inhibitor of dengue protease.

Authors:  Mira A M Behnam; Christoph Nitsche; Sérgio M Vechi; Christian D Klein
Journal:  ACS Med Chem Lett       Date:  2014-07-18       Impact factor: 4.345

2.  Ligand-bound structures of the dengue virus protease reveal the active conformation.

Authors:  Christian G Noble; Cheah Chen Seh; Alexander T Chao; Pei Yong Shi
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

3.  Inhibitors of Dengue virus and West Nile virus proteases based on the aminobenzamide scaffold.

Authors:  Sridhar Aravapalli; Huiguo Lai; Tadahisa Teramoto; Kevin R Alliston; Gerald H Lushington; Eron L Ferguson; R Padmanabhan; William C Groutas
Journal:  Bioorg Med Chem       Date:  2012-05-10       Impact factor: 3.641

Review 4.  Targeting the protease of West Nile virus.

Authors:  Saan Voss; Christoph Nitsche
Journal:  RSC Med Chem       Date:  2021-05-26

Review 5.  Mosquito-Borne Flaviviruses and Current Therapeutic Advances.

Authors:  Xijing Qian; Zhongtian Qi
Journal:  Viruses       Date:  2022-06-05       Impact factor: 5.818

6.  NMR analysis of a novel enzymatically active unlinked dengue NS2B-NS3 protease complex.

Authors:  Young Mee Kim; Shovanlal Gayen; CongBao Kang; Joma Joy; Qiwei Huang; Angela Shuyi Chen; John Liang Kuan Wee; Melgious Jin Yan Ang; Huichang Annie Lim; Alvin W Hung; Rong Li; Christian G Noble; Le Tian Lee; Andy Yip; Qing-Yin Wang; Cheng San Brian Chia; Jeffrey Hill; Pei-Yong Shi; Thomas H Keller
Journal:  J Biol Chem       Date:  2013-03-19       Impact factor: 5.157

Review 7.  The flavivirus protease as a target for drug discovery.

Authors:  Matthew Brecher; Jing Zhang; Hongmin Li
Journal:  Virol Sin       Date:  2013-11-14       Impact factor: 4.327

8.  New binding site conformations of the dengue virus NS3 protease accessed by molecular dynamics simulation.

Authors:  Hugo de Almeida; Izabela M D Bastos; Bergmann M Ribeiro; Bernard Maigret; Jaime M Santana
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

9.  Development and utility of an in vitro, fluorescence-based assay for the discovery of novel compounds against dengue 2 viral protease.

Authors:  Gianne Eduard L Ulanday; Kenta Okamoto; Kouichi Morita
Journal:  Trop Med Health       Date:  2016-08-10

Review 10.  West Nile virus drug discovery.

Authors:  Siew Pheng Lim; Pei-Yong Shi
Journal:  Viruses       Date:  2013-12-03       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.